Abstract
Bucillamine (Bc) is a cysteine derivative with two SH groups, and a homolog of D-penicillamine, a disease-modifying antirheumatic drug (DMARD) widely used in Japan. However, it remains unclear whether Bc repairs bone erosion in patients with RA. Here, we treated three RA patients with Bc who subsequently showed radiographic repair of erosions and cysts.
MeSH terms
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Arthritis, Rheumatoid / diagnostic imaging*
-
Arthritis, Rheumatoid / drug therapy*
-
Arthritis, Rheumatoid / pathology
-
Arthrography
-
Bone and Bones / diagnostic imaging*
-
Bone and Bones / pathology*
-
Cysteine / analogs & derivatives*
-
Cysteine / therapeutic use
-
Disease Progression
-
Female
-
Humans
-
Joints / pathology
-
Male
-
Middle Aged
-
Recovery of Function
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Cysteine
-
bucillamine